Aging Clinical and Experimental Research

, Volume 13, Issue 2, pp 122–130

Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women

  • A. Scuteri
  • E. G. Lakatta
  • A. J. G. Bos
  • J. L. Fleg
Original Articles


Our objectives were to investigate whether long- term estrogen replacement therapy (ERT) is associated with a reduction in age- associated increases in arterial stiffness and blood pressure (BP), and whether the addition of progestin modifies the effects of estrogen. ERT has been found to have beneficial effects on cardiovascular risk. There are few data, however, delineating the effects of ERT on BP and arterial stiffness, and their age- associated changes. BP and aorto- femoral pulse wave velocity (PWV) were measured in 134 postmenopausal volunteers, aged 51 to 90 years, from the Baltimore Longitudinal Study of Aging, screened to exclude clinical and occult cardiovascular disease, and classified as ERT non- users (N=57) or ERT users (N=77). The latter group was further substratified according to the use of estrogen alone (N=32) or a combination of estrogen and progestins (N=45). ERT users showed similar body habitus, physical activity, and plasma lipids compared to non- ERT users. ERT was associated with an average 9.8 mmHg lower systolic BP (p<0.001), and a 6.3 mmHg lower pulse pressure (p<0.01) than in non- users. Multiple regression analysis showed that ERT was an independent predictor of lower SBP and PP (p<0.05). By analysis of covariance, ERT predicted a reduced age- associated increase in SBP, PP, and PWV (p<0.05). When systolic BP was >130 mmHg, the combination of ERT and progestins predicted a higher PWV than ERT alone. In conclusion, ERT in postmenopausal women can beneficially affect the vascular system, by reducing BP and the age- associated increase in arterial stiffness. The addition of progestins to ERT may reduce these beneficial effects.

Key Words

Arterial stiffness blood pressure estrogen replacement menopause progestin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kannel W.B., Hjortland M.C., McNamara P.M., Gordon T.: Menopause and risk of cardiovascular disease: the Framingham study. Ann. Intern. Med. 85: 447–452, 1976.PubMedCrossRefGoogle Scholar
  2. 2.
    Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H.: Menopause and the risk of coronary heart disease in women. N. Engl. J. Med. 316: 1105–1110, 1987.PubMedCrossRefGoogle Scholar
  3. 3.
    Stampfer M.J., Colditz G.A., Willett W.C.: Postmenopausal estrogen therapy and cardiovascular disease. N. Engl. J. Med. 325: 756–762, 1993.CrossRefGoogle Scholar
  4. 4.
    Sack M.N., Rader D.J., Cannon R.O.: Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343: 267–270, 1994.Google Scholar
  5. 5.
    Magness R.R., Rosenfield C.R.: Local and systemic estradiol 17- on uterine and systemic vasodilation. Am. J. Physiol. 256: E536–E542, 1989.PubMedGoogle Scholar
  6. 6.
    Gilligan D., Quyyumi A.A., Cannon R.O.: Effect of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89: 2545–2551, 1994.PubMedCrossRefGoogle Scholar
  7. 7.
    Collins P., Shay J., Jiang C., Moss J.: Nitric oxide account to dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 90: 1964–1968, 1994.PubMedCrossRefGoogle Scholar
  8. 8.
    Jiang C., Sanrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P.: Endothelium independent relaxation of rabbit coronary arteries by 17- estradiol. Br. J. Pharmacol. 104: 1033–1037, 1991.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Collins P., Rosano G.M.C., Jiang C., Lindsay D., Sanrel P.M., Poole-Wilson P.A.: Cardiovascular protection by estrogen. A calcium antagonist effect. Lancet 341: 1264–1265, 1993.PubMedCrossRefGoogle Scholar
  10. 10.
    Matthews K.A., Meilahn E., Kuller L.H., Kelsey S.F., Caggiula A.W., Wing R.R.: Menopause and risk factors for coronary heart disease. N. Engl. J. Med. 312: 641–646, 1989.CrossRefGoogle Scholar
  11. 11.
    Akhaoshi M., Soda M., Nakashima E., Shimaoka K., Seto S., Yano K.: Effects of menopause on trends of serum cholesterol, blood pressure and body mass index. Circulation 94: 61–66, 1996.CrossRefGoogle Scholar
  12. 12.
    Staessen J., Bulpitt C., Fagard R., Lijinen R., Amery A.: The influence of menopause on blood pressure. J. Hum. Hypertens. 3: 427–433, 1989.PubMedGoogle Scholar
  13. 13.
    Lip G., Beevers M., Churchill D., Beevers D.G.: Hormone replacement therapy and blood pressure in hypertensive women. J. Hum. Hypertens. 8: 491–494, 1994.PubMedGoogle Scholar
  14. 14.
    Hayward C.S., Knight D.C., Wren B.G., Kelly R.P.: Effect of hormone replacement therapy on non-invasive cardiovascular haemodynamics. J. Hypertens. 15: 987–993, 1997.PubMedCrossRefGoogle Scholar
  15. 15.
    Lind T., Cameron E.C., Hunter W.M., Leon C., Moran P.F., Oxley A., Gerrard J., Lind U.C.: A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br. J. Obstet. Gynaecol. 86 (Suppl. 3): 1–30, 1979.PubMedCrossRefGoogle Scholar
  16. 16.
    Wren B.G., Routledge A.D.: The effect of type and dose of oestrogen on the blood pressure of postmenopausal women. Maturitas 5: 135–142, 1983.PubMedCrossRefGoogle Scholar
  17. 17.
    Rajkumar C., Kingwell B.A., Cameron J.A., Waddel T., Mehra R., Christophidis N., Komesaroff P.A., McGrath B., Jennings G.L., Sudhir K., Dart A.M.: Hormonal therapy increases arterial compliance in postmenopausal women. J. Am. Coll. Cardiol. 30: 350–356, 1997.PubMedCrossRefGoogle Scholar
  18. 18.
    McGrath B.P., Liang Y.L., Teede H., Shiel L.M., Cameron J.D., Dart A.: Age-related deterioration in arterial structure and function in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 18: 1149–1156, 1998.PubMedCrossRefGoogle Scholar
  19. 19.
    Arnett D.K., Evans G.W., Riley W.A.: Arterial stiffness: a new cardiovascular risk factor? Am. J. Epidemiol. 140: 669–682, 1994.PubMedGoogle Scholar
  20. 20.
    Randall O.S., Van Den Bos G.C., Westerhof A.N.: Systemic compliance: does it play a role in the genesis of essential hypertension? Cardiovasc. Res. 18: 455–462, 1984.PubMedCrossRefGoogle Scholar
  21. 21.
    Mozersky D.J., Sumner D.S., Hokanson D.E., Strandness D.E.: Transcutaneous measurements of the elastic properties of the human femoral artery. Circulation 46: 948–955, 1972.PubMedCrossRefGoogle Scholar
  22. 22.
    Scuteri A., Cacciafesta M., Di Bernardo M.G., De Propris A.M., Recchi D., Celli V., Cicconetti P., Marigliano V.: Pulsatile versus steady-state component of blood pressure in elderly females: an independent risk factor for cardiovascular disease? J. Hypertens. 13: 185–191, 1995.PubMedGoogle Scholar
  23. 23.
    Benetos A., Safar M., Rudnichi A., Smulyan H., Richard J.L., Ducimetiere P., Guize L.: Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 30: 1410–1415, 1997.PubMedCrossRefGoogle Scholar
  24. 24.
    Franklin S.S., Khan S.A., Wong N.D., Larson M.G., Levy D.: Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 100: 354–360, 1999.PubMedCrossRefGoogle Scholar
  25. 25.
    Wenger N.K., Speroff L., Packard B.: Cardiovascular health and disease in women. N. Engl. J. Med. 329: 247–256, 1993.PubMedCrossRefGoogle Scholar
  26. 26.
    Meirik O.: Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 346: 1582–1588, 1995.CrossRefGoogle Scholar
  27. 27.
    Grodstein F., Stampfer M.J., Manson J.E.: Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N. Engl. J. Med. 335: 453–461, 1996.PubMedCrossRefGoogle Scholar
  28. 28.
    Miyagawa K., Rosch J., Stanczyk F., Hermsmeyer K.: Medroxy-progesterone interferes with ovarian steroid protection against coronary vasospasm. Nat. Med. 3: 324–327, 1997.PubMedCrossRefGoogle Scholar
  29. 29.
    Verbugge L.M., Gruber-Baldini A.L., Fozard J.L.: Age differences and age changes in activities: Baltimore Longitudinal Study of Aging. J. Gerontol. 51: S30–S41, 1996.CrossRefGoogle Scholar
  30. 30.
    Ainsworth B.E., Haskell W.L., Leon A.S., Jacobs D.R., Montoye J.J., Sallis J.F., Paffenbarger R.S.Jr.: Compendium of physical activities: Classification of energy costs of human physical activities. Med. Sci. Sports Exerc. 25: 71–80, 1993.PubMedCrossRefGoogle Scholar
  31. 31.
    Jette’ M., Sidney K., Blumchen G.: Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin. Cardiol. 13: 555–565, 1991.CrossRefGoogle Scholar
  32. 32.
    Vaitkevicius P.V., Fleg J.L., Engel J.H., O’Connor F.C., Wright J.G., Lakatta L.E., Yin F.C., Lakatta E.G.: Effects of age and aerobic capacity on arterial stiffness in adults. Circulation 88: 1456–1462, 1993.PubMedCrossRefGoogle Scholar
  33. 33.
    Landahl S., Bengtsson C., Sigurdsson J.A., Svanborg A., Svardsudd K.: Age-related changes in blood pressure. Hypertension 8: 1044–1049, 1986.PubMedCrossRefGoogle Scholar
  34. 34.
    Anastos K., Charney P., Charon R.A., Cohen E., Jones C.Y., Marte C., Swiderski D.M., Wheat M.E., Williams S.: Hypertension in women: what is really known? The Women’s Caucus, Working Group on Women’s Health of the Society of General Internal Medicine. Ann. Intern. Med. 115: 287–293, 1991.PubMedCrossRefGoogle Scholar
  35. 35.
    Avolio A.P., Cheng S.G., Wang R.P., Zhang C., Li M.F., O’Rourke M.F.: Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 68: 50–58, 1983.PubMedCrossRefGoogle Scholar
  36. 36.
    Laogun A.A., Gosling R.G.: In vivo arterial compliance in man. Clin. Phys. Physiol. Meas. 3: 201–212, 1982.PubMedCrossRefGoogle Scholar
  37. 37.
    SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265: 3255–3264, 1991.CrossRefGoogle Scholar
  38. 38.
    Kawano H., Motoyama T., Kugiyama K., Hirashima O., Ohgushi M., Fujii H., Ogawa H., Yasue H.: Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. J. Am. Coll. Cardiol. 30: 914–919, 1997.PubMedCrossRefGoogle Scholar
  39. 39.
    Majmudar N.G., Robson S.C., Ford G.A.: Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J. Clin. Endocrinol. Metab. 85: 1577–1583, 2000.PubMedCrossRefGoogle Scholar
  40. 40.
    Karpanou E.A., Vyssoulis G.P., Papakyriakou S.A., Toutouza M.G., Toutouzas P.K.: Effects of menopause on aortic root function in hypertensive women. J. Am. Coll. Cardiol. 28: 1562–1566, 1996.PubMedCrossRefGoogle Scholar
  41. 41.
    Tanaka H., DeSouza C.A., Seals D.R.: Arterial stiffness and hormone replacement use in healthy postmenopausal women. J. Gerontol. 53: M344–M346, 1998.CrossRefGoogle Scholar
  42. 42.
    Mercuro G., Zoncu S., Paoletti A.M., Melis G.B., Vacca A.M., Cherchi A.: Study of myocardial contractility by pulsed wave Doppler tissue imaging does not reveal an inotropic effect of estrogen at physiologic dose. Am. J. Cardiol. 83: 1677–1679, 1999.PubMedCrossRefGoogle Scholar
  43. 43.
    Snabes M.C., Payne J.P., Kopelen H.A., Dunn J.K., Young R.L., Zoghbi W.A.: Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double-blind, placebo-controlled, crossover trial. Obstet. Gynecol. 89: 332–339, 1997.PubMedCrossRefGoogle Scholar
  44. 44.
    Pines A., Fisman E.Z., Levo Y., Averbuch M., Lidor A., Drory Y., Finkelstein A., Hetman-Peri M., Moshkowitz M., Ben-Ari E., Ayalon D.: The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow. Am. J. Obstet. Gynecol. 164: 806–812, 1991.PubMedCrossRefGoogle Scholar
  45. 45.
    Prelevic G.M., Beljic T.: The effect of oestrogen and progestogen replacement therapy on systolic flow velocity in healthy postmenopausal women. Maturitas 20: 37–44, 1994.PubMedCrossRefGoogle Scholar
  46. 46.
    Hayward C.S., Kalnins W.V., Kelly R.P.: Acute effects of 17beta-estradiol on ventricular and vascular hemodynamics in postmenopausal women. Am. J. Physiol. Heart Circ. Physiol. 279: H2277–H2284, 2000.PubMedGoogle Scholar
  47. 47.
    Fischer G., Swain M.: Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats. Am. J. Physiol. 232: H617–H621, 1977.PubMedGoogle Scholar
  48. 48.
    Vargas R., Wroblewska B., Rego A., Hatch J., Ranwell P.W.: Oestradiol inhibits smooth muscle cell proliferation of pig coronary arteries. Br. J. Clin. Pharmacol. 109: 612–617, 1993.CrossRefGoogle Scholar
  49. 49.
    Register T.C., Adams M.R., Golden D.L., Clarkson T.B.: Conjugated equine estrogen alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys. Arterioscler. Thromb. Vasc. Biol. 18: 1164–1171, 1998.PubMedCrossRefGoogle Scholar
  50. 50.
    Nichols W.W., O’Rourke M.F.: Mc Donald’s blood flow in arteries: Theoretical, experimental and clinical principles, ed. 3. Lea & Febiger, Philadelphia, Pa, 1990.Google Scholar

Copyright information

© Springer Internal Publishing Switzerland 2001

Authors and Affiliations

  • A. Scuteri
    • 1
  • E. G. Lakatta
    • 1
  • A. J. G. Bos
    • 1
  • J. L. Fleg
    • 1
  1. 1.Laboratory of Cardiovascular ScienceGerontology Research Center, NIA - NIHBaltimoreUSA

Personalised recommendations